The addition of polatuzumab vedotin to bendamustine and rituximab (Rituxan; BR) induced a higher rate of complete responses by PET scan (PET-CR) compared with BR alone in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), according to phase II findings presented by Laurie H. Sehn, MD, during the 2018 European Hematology Association Congress. {read more here}

PET can be safely used to guide treatment in patients with untreated advanced-stage classical Hodgkin lymphoma after 2 cycles of upfront de-escalated BEACOPP (BEAesc), according to findings presented at the 2018 European Hematology Association Congress. {read more here}

….a low-cost, portable PET scanner (P-Arm) that can make PET imaging accessible for interventional procedures. P-Arm has wheels and is a portable PET scanner, similar to that of X-ray C-arm. One set of its detectors moves under the patient, while another set is placed above the patient for complete 360 degree views while the patient is within the scanner.  {read more here}

Despite numerous studies and years of research into the benefits of PET imaging with sodium fluoride (NaF) for cancer patients with bone metastases, the U.S. Centers for Medicare and Medicaid Services (CMS) has again rejected reimbursement coverage. {read more here}